Mosunetuzumab 50242-0243
Product NDC
50242-0243- Manufacturer
- Genentech, Inc.
- Dosage Form
- Liquid
- Product Type
- Drug For Further Processing
- Marketing Start
- March 2, 2022
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Mosunetuzumab | 60 mg/.001L |
Packaging Options(1)
6 L in 1 BAG (50242-243-06)